Literature DB >> 17063559

Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages.

Karen M Cullen1, Zoltán Kócsi, Jonathan Stone.   

Abstract

Amyloid-rich plaques are a feature of the aging human cerebral cortex. We have recently described another feature of aging human cortex, microhaemorrhages, identified by their content of haem, red blood cells, collagen and clotting factors, and their spatial relationship to capillaries. Here we relate microhaemorrhages to amyloid deposits. Observations were made in three groups: patients with no history of dementia, patients with Alzheimer's disease (AD) and patients with Down's syndrome (DS) and dementia. Amyloid deposits and microhaemorrhages were labelled in adjacent sections, amyloid deposits with antibodies to beta-amyloid (betaA), and microhaemorrhages by Prussian blue histochemistry for haem. The densities and sizes of betaA deposits and haem-rich deposits (HRDs), and their relationship to blood vessels, were surveyed in temporal, cingulate and superior frontal cortex. Our results suggest that HRDs and betaA deposits are the same sites of pathology. Their densities in the cortex and white matter of the regions surveyed varied markedly between cases, particularly between demented and non-demented cases, but they always co-varied; where haem deposits were sparse or numerous, so were betaA deposits. Both HRDs and betaA deposits formed adjacent to or encircling small vessels, often at branch points, and a spatial proximity analysis confirmed that both were found close to or colocalising with microvessels. Both HRDs and betaA deposits were associated with blood- or vessel-derived proteins (fibrinogen, von Willebrand factor and collagen VI). Since haem is an established marker of cerebral bleeding, and amyloid is a marker of senile plaques, our results indicate that senile plaques are sites of microhaemorrhages. This colocalisation raises the very testable questions of whether microhaemorrhages are early events in plaque formation and whether therapies which stabilise cerebral microvessels can prevent the onset or slow the progress of dementias associated with plaque formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17063559     DOI: 10.1016/j.neurobiolaging.2005.10.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  70 in total

1.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors:  Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 2.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 3.  Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Authors:  Michael F O'Rourke; Audrey Adji; Mayooran Namasivayam; Jonathan Mok
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

4.  Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.

Authors:  Matthew Schrag; Andrew Crofton; Matthew Zabel; Arshad Jiffry; David Kirsch; April Dickson; Xiao Wen Mao; Harry V Vinters; Dylan W Domaille; Christopher J Chang; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Rust on the Brain from Microbleeds and Its Relevance to Alzheimer Studies: Invited Commentary on Cacciottolo Neurobiology of Aging, 2016.

Authors:  M Cacciottolo; T E Morgan; C E Finch
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-24

Review 6.  Genetic and epigenetic regulation of human aging and longevity.

Authors:  Brian J Morris; Bradley J Willcox; Timothy A Donlon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-01       Impact factor: 5.187

Review 7.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

8.  The effects of healthy aging on intracerebral blood vessels visualized by magnetic resonance angiography.

Authors:  Elizabeth Bullitt; Donglin Zeng; Benedicte Mortamet; Arpita Ghosh; Stephen R Aylward; Weili Lin; Bonita L Marks; Keith Smith
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

9.  Changes in intracranial venous blood flow and pulsatility in Alzheimer's disease: A 4D flow MRI study.

Authors:  Leonardo A Rivera-Rivera; Tilman Schubert; Patrick Turski; Kevin M Johnson; Sara E Berman; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Oliver Wieben
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 10.  Blood-based biomarkers of microvascular pathology in Alzheimer's disease.

Authors:  Michael Ewers; Michelle M Mielke; Harald Hampel
Journal:  Exp Gerontol       Date:  2009-09-24       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.